We are live on ! Find out more
ELTX icon

Elicio Therapeutics
ELTX

20 hedge funds and large institutions have $2.68M invested in Elicio Therapeutics in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 1

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

11% more funds holding

Funds holding: 18 → 20 (+2)

1.48% more ownership

Funds ownership: 4.83% → 6.32% (+1.5%)

13% less capital invested

Capital invested by funds: $3.08M → $2.68M (-$400K)

Holders
20
Holders Change
+2
Holders Change %
+11.11%
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
5
Increased
8
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$846K
2
AI
Arena Investors
New York
+$423K
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$412K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$201K
5
BlackRock
BlackRock
New York
+$153K

Top Sellers

Rank Fund Capital Flow
1
CM
CM Management
Florida
-$211K
2
Renaissance Technologies
Renaissance Technologies
New York
-$89K
3
NCM
Northwest Capital Management
Oregon
-$2.66K
4
Wells Fargo
Wells Fargo
California
-$380
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$930K +$89.7K +10,611 +5%
AC
2
Armistice Capital
New York
$411K +$846K +100,000 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$294K +$201K +23,812 +50%
CM
4
CM Management
Florida
$206K -$211K -25,000 -33%
AI
5
Arena Investors
New York
$206K +$423K +50,000 New
Hudson Bay Capital Management
6
Hudson Bay Capital Management
Connecticut
$200K +$412K +48,720 New
State Street
7
State Street
Massachusetts
$90K +$36.4K +4,300 +24%
BlackRock
8
BlackRock
New York
$78K +$153K +18,068 +1,970%
MHC
9
Meyer Handelman Company
New York
$57.1K – – –
BCM
10
Bridgeway Capital Management
Texas
$51.4K – – –
WAM
11
Warberg Asset Management
Illinois
$48.5K +$99.8K +11,801 New
Northern Trust
12
Northern Trust
Illinois
$46K +$94.6K +11,180 New
CIBC Private Wealth Group
13
CIBC Private Wealth Group
Georgia
$42.6K – – –
SPIA
14
Steward Partners Investment Advisory
New York
$6.39K – – –
National Bank of Canada
15
National Bank of Canada
Quebec, Canada
$5.57K +$6.77K +800 +114%
Bank of America
16
Bank of America
North Carolina
$4.94K +$474 +56 +5%
Citigroup
17
Citigroup
New York
$1.54K – – –
Morgan Stanley
18
Morgan Stanley
New York
$945 +$846 +100 +77%
UBS Group
19
UBS Group
Switzerland
$70 +$8 +1 +6%
Renaissance Technologies
20
Renaissance Technologies
New York
– -$89K -11,761 Closed
NCM
21
Northwest Capital Management
Oregon
– -$2.66K -350 Closed
Wells Fargo
22
Wells Fargo
California
– -$380 -50 Closed

ELTX Hedge Fund Activity: Q2 2024 in Review

20 of the 6,930 institutional investors tracked by Wall St. Rank reported a position in Elicio Therapeutics (ELTX) for Q2 2024, worth a combined $2.68M — down 13% from $3.08M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ELTX positions and 3 closed out — a net gain of 2 holders — while 8 added to existing stakes and 1 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $846K. The largest seller was CM Management, cutting an estimated $211K.

  • 20 institutional investors held Elicio Therapeutics (ELTX) as of Q2 2024, up from 18 in Q1 2024.
  • Funds reported $2.68M of Elicio Therapeutics stock for Q2 2024, down 13% quarter-over-quarter.
  • 5 funds opened new Elicio Therapeutics positions in Q2 2024 and 3 closed out, a net change of +2 holders.
  • The largest Elicio Therapeutics buyer in Q2 2024 was Armistice Capital, an estimated $846K added.
  • The largest Elicio Therapeutics seller in Q2 2024 was CM Management, an estimated $211K sold.

Based on aggregated 13F filings for Q2 2024.